Consun Pharmaceutical Group Limited (FRA:C1P)

FRA:C1P Revenue

Consun Pharmaceutical Group had revenue of 1.57B CNY in the half year ending June 30, 2025, with 40.09% growth. This brings the company's revenue in the last twelve months to 3.27B, up 19.29% year-over-year. In the year 2024, Consun Pharmaceutical Group had annual revenue of 2.97B with 14.56% growth.

• Revenue (ttm): 3.27B CNY
• Revenue Growth: +19.29%
• P/S Ratio: 3.62
• Revenue / Employee: 1.03M CNY
• Employees: 3,164
• Market Cap: 1.41B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.97B	377.12M	14.56%
Dec 31, 2023	2.59B	250.47M	10.71%
Dec 31, 2022	2.34B	294.99M	14.43%
Dec 31, 2021	2.04B	291.83M	16.65%
Dec 31, 2020	1.75B	24.57M	1.42%